TerrAscend (TSNDF) Net Cash Flow (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Net Cash Flow of $1.4 million for Q1 2026, down 76.92% year-over-year from $5.9 million in Q1 2025, and down 89.9% quarter-over-quarter from $13.5 million in Q4 2025.
TerrAscend (TSNDF) Net Cash Flow (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Net Cash Flow for 6 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow fell 76.92% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $19.0 million (up 27.28% YoY), while the FY2025 annual figure was $23.5 million, up 154.05% from the prior year.
- Net Cash Flow declined to $1.4 million in Q1 2026 per TSNDF's latest filing, from $13.5 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $14.2 million in Q1 2022 and bottomed at -$37.1 million in Q2 2022.
- Historically, Net Cash Flow has averaged -$1.3 million across 5 years, with a median of $229000.0 in 2024.
- On a YoY basis, Net Cash Flow climbed as much as 5931.88% in 2025 and fell as far as 139.6% in 2025.
- TerrAscend's Net Cash Flow stood at -$5.2 million in 2022, then plunged by 54.44% to -$8.1 million in 2023, then soared by 52.16% to -$3.9 million in 2024, then soared by 448.88% to $13.5 million in 2025, then sank by 89.9% to $1.4 million in 2026.
- Business Quant data shows TSNDF's Net Cash Flow at $1.4 million in Q1 2026, $13.5 million in Q4 2025, and $9.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn | 3.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.66 Mn |
| Jun 30, 2026 | 3.66 Mn |
| Mar 31, 2026 | 1.36 Mn |
| Mar 31, 2026 | 1.36 Mn |
| Dec 31, 2025 | 13.45 Mn |
| Dec 31, 2025 | 13.45 Mn |
| Sep 30, 2025 | 9.33 Mn |
| Sep 30, 2025 | 9.33 Mn |
| Jun 30, 2025 | -5.16 Mn |
| Jun 30, 2025 | -5.16 Mn |
| Mar 31, 2025 | 5.89 Mn |
| Mar 31, 2025 | 5.89 Mn |
| Dec 31, 2024 | -3.86 Mn |
| Dec 31, 2024 | -3.86 Mn |
| Sep 30, 2024 | -160,000.00 |
| Sep 30, 2024 | -160,000.00 |
| Jun 30, 2024 | 13.04 Mn |
| Jun 30, 2024 | 13.04 Mn |
| Mar 31, 2024 | 229,000.00 |
| Mar 31, 2024 | 229,000.00 |